GH can activate heterodimers consisting of the GHR and the prolactin receptor (PRLR) in breast tissue, activating PRL signaling pathways [14], and GHR-IGF-1R heterodimers may potentiate GH signaling in prostate cancer cells [15]. This evidence concerns the gene GH1 and Familial prostate cancer.